Autopsy report · NCT00033423
Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Cause of deathNo reason given
Life of this trial
- Registered 8 months after it had already started.
- Ran for about 7 years 9 months before it stopped.
- 18 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- University of Alabama at Birmingham
- Sponsor type
- University, hospital or other
- Conditions
- Lymphoma
- Interventions
- rituximab; yttrium Y 90 ibritumomab tiuxetan
- Participants
- 18
- Sites
- 3
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.